Turmeric Acquisition Corp. (NASDAQ:TMPM) announced this morning that it has opted to liquidate its trust, dispersing approximately $10.05 per share to holders.
The SPAC’s shares will cease trading as of the open on October 20. Turmeric will hold on to up to $100,000 of accrued interest to pay for dissolution expenses.
Turmeric originally raised $97.8 million in its October 2020 IPO and endeavored to combine with an “off-the-radar” life sciences company with promising drug candidates for oncology or rare diseases. This has been a particularly tricky field for SPACs seeking to achieve near-term returns in recent years.
Of the 33 drug discovery or development biotech companies that have completed SPAC transactions dating back to May 2019, only one closed Friday above $10 – Immatics Biotechnologies (NASDAQ:IMTX). It completed its combination with ARYA Sciences I in June 2020.
Turmeric becomes the 35th SPAC to announce its intention to liquidate in 2022, 28 of which have already completed their liquidations.


McKinley Acquisition Corporation (NASDAQ:MKLYU) has filed for a $150 million SPAC to hunt for an innovative target company with an experienced financial team that has dabbled in SPACs before. The new SPAC is offering investors one right to a 1/10 share in each unit with no overfunding of the trust, but it could provide a...
At the SPAC of Dawn The rain of SPACs has continued with four expected to make their debuts during today’s trading sessions after pricing their IPOs overnight. The largest of these, EQV Ventures II (NASDAQ:EVACU), even managed an upsize, making it the largest SPAC IPO since Ares II (NYSE:AACT) pulled together $450 million in 2023....
EQV Ventures II (NASDAQ:EVACU) announced the pricing of its upsized $420 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “EVACU”, Wednesday, July 2, 2025. The new SPAC plans to merge with an energy target involved in upstream exploration or production. EQV II’s management team is led by...
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....